Neuromyelitis optica and aquaporin‐4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland
. Purpose: To analyse the frequency of neuromyelitis optica (NMO) among consecutive optic neuritis (ON) patients in Southern Finland and the feasibility of Aquaporin‐4 (AQP4) autoantibody assay in the diagnosis of NMO. Methods: Consecutive patients with symptoms suggestive of acute ON and managed...
Gespeichert in:
Veröffentlicht in: | Acta ophthalmologica (Oxford, England) England), 2014-06, Vol.92 (4), p.387-391 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 391 |
---|---|
container_issue | 4 |
container_start_page | 387 |
container_title | Acta ophthalmologica (Oxford, England) |
container_volume | 92 |
creator | Siuko, Mika Tienari, Pentti J. Saastamoinen, Kari‐Pekka Atula, Sari Miettinen, Aaro Kivelä, Tero Setälä, Kirsi |
description | .
Purpose: To analyse the frequency of neuromyelitis optica (NMO) among consecutive optic neuritis (ON) patients in Southern Finland and the feasibility of Aquaporin‐4 (AQP4) autoantibody assay in the diagnosis of NMO.
Methods: Consecutive patients with symptoms suggestive of acute ON and managed in the Helsinki University Central Hospital were evaluated critically screened for AQP4 autoantibody during a 47.5‐month period. The antibodies were determined using radioimmunoprecipitation method. AQP4 index >15 was considered positive, 10–15 borderline and |
doi_str_mv | 10.1111/aos.12187 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1622599775</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1622599775</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4217-ee9a9172031fb42eb210a7859d6f302dfe78d420ea725a8576f17b5c68c3d4a03</originalsourceid><addsrcrecordid>eNqF0c1qFTEUwPEgiv3QhS8gATft4rb5mOTMLC_FVqFYpQruhszMGUyZm0zzYbk7H8Fn9ElM79QuBDGbZPHLn4RDyCvOTnhZp8bHEy54DU_IPgelVhJ0_fTxrL7ukYMYbxjTXOvqOdkTEkAKIffJ3QfMwW-2ONlkI_Vzsr2hxg3U3GYz-2Ddrx8_K3q0_vSxOqYmJ29csp0fLEZqHe29i9jnZL_jcpu6UtzFZpMsurRj1z6nbxgcPbduKvkX5NlopogvH_ZD8uX87eezd6vLq4v3Z-vLVV8JDivExjQcBJN87CqBneDMQK2aQY-SiWFEqIdKMDQglKkV6JFDp3pd93KoDJOH5GjpzsHfZoyp3djY41TegD7HlmshVNMAqP9TJTRIzbgo9M1f9Mbn4MpH7pWqNUDDizpeVB98jAHHdg52Y8K25ay9H1xbBtfuBlfs64di7jY4PMo_kyrgdAF3dsLtv0vt-up6Sf4GXbii9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1525867791</pqid></control><display><type>article</type><title>Neuromyelitis optica and aquaporin‐4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Wiley Online Library (Open Access Collection)</source><creator>Siuko, Mika ; Tienari, Pentti J. ; Saastamoinen, Kari‐Pekka ; Atula, Sari ; Miettinen, Aaro ; Kivelä, Tero ; Setälä, Kirsi</creator><creatorcontrib>Siuko, Mika ; Tienari, Pentti J. ; Saastamoinen, Kari‐Pekka ; Atula, Sari ; Miettinen, Aaro ; Kivelä, Tero ; Setälä, Kirsi</creatorcontrib><description>.
Purpose: To analyse the frequency of neuromyelitis optica (NMO) among consecutive optic neuritis (ON) patients in Southern Finland and the feasibility of Aquaporin‐4 (AQP4) autoantibody assay in the diagnosis of NMO.
Methods: Consecutive patients with symptoms suggestive of acute ON and managed in the Helsinki University Central Hospital were evaluated critically screened for AQP4 autoantibody during a 47.5‐month period. The antibodies were determined using radioimmunoprecipitation method. AQP4 index >15 was considered positive, 10–15 borderline and <10 normal. Brain magnetic resonance imaging (MRI) was performed for all patients.
Results: Of the 300 patients with suspected ON, 191 were eventually diagnosed as ON, and 66 (35%) of them had a previous diagnosis or were diagnosed with multiple sclerosis (MS). Of the 125 patients without MS diagnosis, 62 (50%) had demyelinative lesions in MRI, which is a risk factor for developing MS. Two patients (1.1%; 95% CI 0.3–4.5) fulfilled the criteria of NMO. Positive AQP4 antibodies were found in three patients (1.6% 95% CI 0.3–4.5), one of them had NMO, one had MS and one became diagnosed with MS a month later. Borderline autoantibody levels were found in 10 patients, 7 of whom had MS.
Conclusions: NMO is rare among ON patients in the population of Southern Finland. In this small cohort, the sensitivity and positive predictive values of the AQP4 autoantibody index for NMO were low, 1/2 and 1/3 respectively, and do not support initiating routine screening.</description><identifier>ISSN: 1755-375X</identifier><identifier>EISSN: 1755-3768</identifier><identifier>DOI: 10.1111/aos.12187</identifier><identifier>PMID: 23773223</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Aquaporin 4 - immunology ; Aquaporins ; aquaporin‐4 autoantibody ; Autoantibodies - blood ; Autoantigens - immunology ; autoimmune optic neuropathy ; Enzyme-Linked Immunosorbent Assay ; Female ; Finland - epidemiology ; Humans ; Magnetic Resonance Imaging ; Male ; Medical research ; Middle Aged ; Multiple sclerosis ; neuromyelitis optica ; Neuromyelitis Optica - diagnosis ; Neuromyelitis Optica - epidemiology ; Neuromyelitis Optica - immunology ; NMR ; Nuclear magnetic resonance ; Ophthalmology ; optic neuritis ; Optic Neuritis - diagnosis ; Optic Neuritis - epidemiology ; Optic Neuritis - immunology ; Radioimmunoprecipitation Assay ; Young Adult</subject><ispartof>Acta ophthalmologica (Oxford, England), 2014-06, Vol.92 (4), p.387-391</ispartof><rights>2013 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4217-ee9a9172031fb42eb210a7859d6f302dfe78d420ea725a8576f17b5c68c3d4a03</citedby><cites>FETCH-LOGICAL-c4217-ee9a9172031fb42eb210a7859d6f302dfe78d420ea725a8576f17b5c68c3d4a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Faos.12187$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Faos.12187$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23773223$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Siuko, Mika</creatorcontrib><creatorcontrib>Tienari, Pentti J.</creatorcontrib><creatorcontrib>Saastamoinen, Kari‐Pekka</creatorcontrib><creatorcontrib>Atula, Sari</creatorcontrib><creatorcontrib>Miettinen, Aaro</creatorcontrib><creatorcontrib>Kivelä, Tero</creatorcontrib><creatorcontrib>Setälä, Kirsi</creatorcontrib><title>Neuromyelitis optica and aquaporin‐4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland</title><title>Acta ophthalmologica (Oxford, England)</title><addtitle>Acta Ophthalmol</addtitle><description>.
Purpose: To analyse the frequency of neuromyelitis optica (NMO) among consecutive optic neuritis (ON) patients in Southern Finland and the feasibility of Aquaporin‐4 (AQP4) autoantibody assay in the diagnosis of NMO.
Methods: Consecutive patients with symptoms suggestive of acute ON and managed in the Helsinki University Central Hospital were evaluated critically screened for AQP4 autoantibody during a 47.5‐month period. The antibodies were determined using radioimmunoprecipitation method. AQP4 index >15 was considered positive, 10–15 borderline and <10 normal. Brain magnetic resonance imaging (MRI) was performed for all patients.
Results: Of the 300 patients with suspected ON, 191 were eventually diagnosed as ON, and 66 (35%) of them had a previous diagnosis or were diagnosed with multiple sclerosis (MS). Of the 125 patients without MS diagnosis, 62 (50%) had demyelinative lesions in MRI, which is a risk factor for developing MS. Two patients (1.1%; 95% CI 0.3–4.5) fulfilled the criteria of NMO. Positive AQP4 antibodies were found in three patients (1.6% 95% CI 0.3–4.5), one of them had NMO, one had MS and one became diagnosed with MS a month later. Borderline autoantibody levels were found in 10 patients, 7 of whom had MS.
Conclusions: NMO is rare among ON patients in the population of Southern Finland. In this small cohort, the sensitivity and positive predictive values of the AQP4 autoantibody index for NMO were low, 1/2 and 1/3 respectively, and do not support initiating routine screening.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aquaporin 4 - immunology</subject><subject>Aquaporins</subject><subject>aquaporin‐4 autoantibody</subject><subject>Autoantibodies - blood</subject><subject>Autoantigens - immunology</subject><subject>autoimmune optic neuropathy</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Finland - epidemiology</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical research</subject><subject>Middle Aged</subject><subject>Multiple sclerosis</subject><subject>neuromyelitis optica</subject><subject>Neuromyelitis Optica - diagnosis</subject><subject>Neuromyelitis Optica - epidemiology</subject><subject>Neuromyelitis Optica - immunology</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Ophthalmology</subject><subject>optic neuritis</subject><subject>Optic Neuritis - diagnosis</subject><subject>Optic Neuritis - epidemiology</subject><subject>Optic Neuritis - immunology</subject><subject>Radioimmunoprecipitation Assay</subject><subject>Young Adult</subject><issn>1755-375X</issn><issn>1755-3768</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0c1qFTEUwPEgiv3QhS8gATft4rb5mOTMLC_FVqFYpQruhszMGUyZm0zzYbk7H8Fn9ElM79QuBDGbZPHLn4RDyCvOTnhZp8bHEy54DU_IPgelVhJ0_fTxrL7ukYMYbxjTXOvqOdkTEkAKIffJ3QfMwW-2ONlkI_Vzsr2hxg3U3GYz-2Ddrx8_K3q0_vSxOqYmJ29csp0fLEZqHe29i9jnZL_jcpu6UtzFZpMsurRj1z6nbxgcPbduKvkX5NlopogvH_ZD8uX87eezd6vLq4v3Z-vLVV8JDivExjQcBJN87CqBneDMQK2aQY-SiWFEqIdKMDQglKkV6JFDp3pd93KoDJOH5GjpzsHfZoyp3djY41TegD7HlmshVNMAqP9TJTRIzbgo9M1f9Mbn4MpH7pWqNUDDizpeVB98jAHHdg52Y8K25ay9H1xbBtfuBlfs64di7jY4PMo_kyrgdAF3dsLtv0vt-up6Sf4GXbii9A</recordid><startdate>201406</startdate><enddate>201406</enddate><creator>Siuko, Mika</creator><creator>Tienari, Pentti J.</creator><creator>Saastamoinen, Kari‐Pekka</creator><creator>Atula, Sari</creator><creator>Miettinen, Aaro</creator><creator>Kivelä, Tero</creator><creator>Setälä, Kirsi</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>201406</creationdate><title>Neuromyelitis optica and aquaporin‐4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland</title><author>Siuko, Mika ; Tienari, Pentti J. ; Saastamoinen, Kari‐Pekka ; Atula, Sari ; Miettinen, Aaro ; Kivelä, Tero ; Setälä, Kirsi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4217-ee9a9172031fb42eb210a7859d6f302dfe78d420ea725a8576f17b5c68c3d4a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aquaporin 4 - immunology</topic><topic>Aquaporins</topic><topic>aquaporin‐4 autoantibody</topic><topic>Autoantibodies - blood</topic><topic>Autoantigens - immunology</topic><topic>autoimmune optic neuropathy</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Finland - epidemiology</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical research</topic><topic>Middle Aged</topic><topic>Multiple sclerosis</topic><topic>neuromyelitis optica</topic><topic>Neuromyelitis Optica - diagnosis</topic><topic>Neuromyelitis Optica - epidemiology</topic><topic>Neuromyelitis Optica - immunology</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Ophthalmology</topic><topic>optic neuritis</topic><topic>Optic Neuritis - diagnosis</topic><topic>Optic Neuritis - epidemiology</topic><topic>Optic Neuritis - immunology</topic><topic>Radioimmunoprecipitation Assay</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Siuko, Mika</creatorcontrib><creatorcontrib>Tienari, Pentti J.</creatorcontrib><creatorcontrib>Saastamoinen, Kari‐Pekka</creatorcontrib><creatorcontrib>Atula, Sari</creatorcontrib><creatorcontrib>Miettinen, Aaro</creatorcontrib><creatorcontrib>Kivelä, Tero</creatorcontrib><creatorcontrib>Setälä, Kirsi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Acta ophthalmologica (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Siuko, Mika</au><au>Tienari, Pentti J.</au><au>Saastamoinen, Kari‐Pekka</au><au>Atula, Sari</au><au>Miettinen, Aaro</au><au>Kivelä, Tero</au><au>Setälä, Kirsi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuromyelitis optica and aquaporin‐4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland</atitle><jtitle>Acta ophthalmologica (Oxford, England)</jtitle><addtitle>Acta Ophthalmol</addtitle><date>2014-06</date><risdate>2014</risdate><volume>92</volume><issue>4</issue><spage>387</spage><epage>391</epage><pages>387-391</pages><issn>1755-375X</issn><eissn>1755-3768</eissn><abstract>.
Purpose: To analyse the frequency of neuromyelitis optica (NMO) among consecutive optic neuritis (ON) patients in Southern Finland and the feasibility of Aquaporin‐4 (AQP4) autoantibody assay in the diagnosis of NMO.
Methods: Consecutive patients with symptoms suggestive of acute ON and managed in the Helsinki University Central Hospital were evaluated critically screened for AQP4 autoantibody during a 47.5‐month period. The antibodies were determined using radioimmunoprecipitation method. AQP4 index >15 was considered positive, 10–15 borderline and <10 normal. Brain magnetic resonance imaging (MRI) was performed for all patients.
Results: Of the 300 patients with suspected ON, 191 were eventually diagnosed as ON, and 66 (35%) of them had a previous diagnosis or were diagnosed with multiple sclerosis (MS). Of the 125 patients without MS diagnosis, 62 (50%) had demyelinative lesions in MRI, which is a risk factor for developing MS. Two patients (1.1%; 95% CI 0.3–4.5) fulfilled the criteria of NMO. Positive AQP4 antibodies were found in three patients (1.6% 95% CI 0.3–4.5), one of them had NMO, one had MS and one became diagnosed with MS a month later. Borderline autoantibody levels were found in 10 patients, 7 of whom had MS.
Conclusions: NMO is rare among ON patients in the population of Southern Finland. In this small cohort, the sensitivity and positive predictive values of the AQP4 autoantibody index for NMO were low, 1/2 and 1/3 respectively, and do not support initiating routine screening.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>23773223</pmid><doi>10.1111/aos.12187</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1755-375X |
ispartof | Acta ophthalmologica (Oxford, England), 2014-06, Vol.92 (4), p.387-391 |
issn | 1755-375X 1755-3768 |
language | eng |
recordid | cdi_proquest_miscellaneous_1622599775 |
source | MEDLINE; Access via Wiley Online Library; Wiley Online Library (Open Access Collection) |
subjects | Adolescent Adult Aquaporin 4 - immunology Aquaporins aquaporin‐4 autoantibody Autoantibodies - blood Autoantigens - immunology autoimmune optic neuropathy Enzyme-Linked Immunosorbent Assay Female Finland - epidemiology Humans Magnetic Resonance Imaging Male Medical research Middle Aged Multiple sclerosis neuromyelitis optica Neuromyelitis Optica - diagnosis Neuromyelitis Optica - epidemiology Neuromyelitis Optica - immunology NMR Nuclear magnetic resonance Ophthalmology optic neuritis Optic Neuritis - diagnosis Optic Neuritis - epidemiology Optic Neuritis - immunology Radioimmunoprecipitation Assay Young Adult |
title | Neuromyelitis optica and aquaporin‐4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T04%3A29%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuromyelitis%20optica%20and%20aquaporin%E2%80%904%20(AQP4)%20autoantibodies%20in%20consecutive%20optic%20neuritis%20patients%20in%20Southern%20Finland&rft.jtitle=Acta%20ophthalmologica%20(Oxford,%20England)&rft.au=Siuko,%20Mika&rft.date=2014-06&rft.volume=92&rft.issue=4&rft.spage=387&rft.epage=391&rft.pages=387-391&rft.issn=1755-375X&rft.eissn=1755-3768&rft_id=info:doi/10.1111/aos.12187&rft_dat=%3Cproquest_cross%3E1622599775%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1525867791&rft_id=info:pmid/23773223&rfr_iscdi=true |